HMG-CoA reductase inhibitors (Columbia University/Columbia Technology Ventures)

N/A

Report date: 2025/03/20 15:14:49
NME

Base Information

Drug NameHMG-CoA reductase inhibitors (Columbia University/Columbia Technology Ventures)
Drug Alias Namestatins (Columbia University/Columbia Technology Ventures)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesColumbia Technology VenturesColumbia University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A